SVV Sees 8.8% U.S. Sales Growth and 68% Upside to $17.67
SVV’s Piotroski Score of 8 and 68.13% upside to a $17.67 target price highlight its strong financial health and undervaluation. In Q4 2025, adjusted EBITDA grew year-over-year for the first time in two years with U.S. comparable sales up 8.8% and $17 million in annual interest expense savings.
1. Undervaluation and Financial Health
SVV’s Piotroski Score of 8 reflects strong profitability, leverage, liquidity and operating efficiency. With a projected 68.13% upside to the $17.67 target price, the stock is considered undervalued despite recent short-term price declines.
2. Q4 2025 Performance Highlights
Adjusted EBITDA grew year-over-year for the first time in two years, marking a strategic inflection as new store cohorts mature. U.S. comparable sales rose 8.8% driven by younger affluent shoppers, while Canadian comps stabilized at 0.7% with improved segment profit.
3. Store Expansion and Capital Strategy
New stores continue to track toward the five-year 20% contribution margin target, matching internal forecasts. Management restructured capital to reduce annual interest expense by $17 million, prioritizing high-return store openings.